July 05, 2016
Warp Drive Bio
Warp Drive Bio Appoints Rachel K. King to its Board of Directors
June 29, 2016
GBT
Global Blood Therapeutics Announces Initiation of Phase 2a Study of GBT440 in Adolescents with Sickle Cell Disease
June 29, 2016
Foundation Medicine
Foundation Medicine Announces Release of Molecular Information from FoundationCOREâ„¢ to the National Cancer Institute in Support of the National Cancer Moonshot and Precision Medicine Initiatives
June 22, 2016
Voyager Therapeutics
Voyager Therapeutics Announces Interim Phase 1b Surgical Results for VY-AADC01 in Advanced Parkinson's Disease
June 20, 2016
GBT
Global Blood Therapeutics Announces Pricing of Public Offering of Common Stock